Deadline for manuscript submissions: 10 December 2021Print Special Issue Flyer (11)
Professor of Dept. of Emergency Medicine, Univ. of Health Sciences, Istanbul Education and Research Hospital, Fatih, Istanbul, Turkey
Interests: Cardiopulmonary resuscitation, Emergency management, Pain management, Trauma, Intensive Care Medicine
Sudden cardiac death and in- and out-of-hospital cardiac arrest (IHCA/OHCA) are common final pathways to death in most parts of the world, especially in the adult population. Only a minority of those patients who are successfully resuscitated with return of spontaneous circulation (ROSC) are able to survive to hospital discharge with a favorable neurologic status. The majority of in-hospital deaths from resuscitated victims of cardiac arrest have been attributed to neurologic injury. Current guidelines recommend consideration of therapeutic hypothermia (TH) for the management of comatose survivors of cardiac arrest. Standardized management of the victims of cardiac arrest which comprise organization of a TH program can be extremely difficult and necessitates a multidisciplinary team approach. Acute coronary syndromes are blamed for a significant percentage of cases with cardiac arrest, and feasibility of percutaneous coronary intervention in the emergency setting coupled with TH when indicated will pave the way to improved survival in this group of patients. Intracranial hemorrhages including subarachnoid hemorrhages and severe head injury also constitute other major indications for TH to provide neuroprotection. On the other hand, there is a considerable frequency of adverse effects linked to the procedure which can also constitute drawbacks. The objective of this special issue is to help healthcare providers conceptualize the current advances in implementation, indications, drawbacks, practical tips of TH for the practitioner, post-resuscitation care in emergency and critical care in this group of patients. Clinical research and review / state-of-the-art articles, case reports or case series on the procedure are welcomed.
Cardiac arrest, Therapeutic hypothermia, Adverse effects, Targeted temperature management, Intracranial hemorrhage, Resuscitation
Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.
Cerebral oxygenation monitoring in patients during and after cardiac arrest -- a narrative review of current methods and evidence
Online publish date: 24 August 2021
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.